Form 4 · Filed Jun 22, 2026, 09:47 PM UTC
KYMR/Kymera Therapeutics, Inc.
Goodman Noah — Chief Business Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
3 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 22, 2026 | M | other | 2,500 | $21 | $52,625 | 52,695 |
| Jun 22, 2026 | S | sell | 2,500 | $99 | $247,500 | 50,195 |
| Jun 22, 2026 | M | other | 2,500 | — | — | 95,000 |
Source: SEC EDGAR raw filing ↗ · Accession 0001193125-26-277766